An inducible Cldn11‐CreERT2 mouse line for selective targeting of lymphatic valves

Abstract excerpt

Abstract Luminal valves of collecting lymphatic vessels are critical for maintaining unidirectional flow of lymph and their dysfunction underlies several forms of primary lymphedema. Here, we report on the generation of a transgenic mouse expressing the tamoxifen inducible CreERT2 under the control of Cldn11 promoter that allows, for the first time, selective and temporally controlled targeting of lymphatic valve...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Lymphatic System and Diseases
• Share to Sympathectomy and Hyperhidrosis Treatments